These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36289602)

  • 1. Immunomodulation by Hemoadsorption-Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study.
    Praxenthaler J; Schwier E; Altmann S; Kirchner C; Bialas J; Henzler D; Köhler T
    Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentered prospective investigator initiated study to evaluate the clinical outcomes with extracorporeal cytokine adsorption device (CytoSorb
    Paul R; Sathe P; Kumar S; Prasad S; Aleem M; Sakhalvalkar P
    World J Crit Care Med; 2021 Jan; 10(1):22-34. PubMed ID: 33505870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test.
    Kaffarnik MF; Lock JF; Vetter H; Ahmadi N; Lojewski C; Malinowski M; Neuhaus P; Stockmann M
    Crit Care; 2013 Oct; 17(5):R259. PubMed ID: 24172237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Evaluation of a New Dynamic Scoring System Intended to Support Prescription of Adjuvant CytoSorb Hemoadsorption Therapy in Patients with Septic Shock.
    Kogelmann K; Hübner T; Schwameis F; Drüner M; Scheller M; Jarczak D
    J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34209001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review with expert consensus on use of extracorporeal hemoadsorption in septic shock: An Indian perspective.
    Mehta Y; Ansari AS; Mandal AK; Chatterjee D; Sharma GS; Sathe P; Umraniya PV; Paul R; Gupta S; Singh V; Singh YP
    World J Crit Care Med; 2024 Mar; 13(1):89026. PubMed ID: 38633478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoadsorption by CytoSorb in septic patients: a case series.
    Kogelmann K; Jarczak D; Scheller M; Drüner M
    Crit Care; 2017 Mar; 21(1):74. PubMed ID: 28343448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemoadsorption by extracorporeal cytokine adsorption therapy (CytoSorb
    Singh YP; Chhabra SC; Lashkari K; Taneja A; Garg A; Chandra A; Chhabra M; Singh GP; Jain S
    Int J Artif Organs; 2020 Jun; 43(6):372-378. PubMed ID: 31868078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multi-organ dysfunction: A case study.
    Basu R; Pathak S; Goyal J; Chaudhry R; Goel RB; Barwal A
    Indian J Crit Care Med; 2014 Dec; 18(12):822-4. PubMed ID: 25538418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of CytoSorb and CKRT on hemodynamics in pediatric patients with septic shock: the PedCyto study.
    Bottari G; Guzzo I; Cappoli A; Labbadia R; Perdichizzi S; Serpe C; Creteur J; Cecchetti C; Taccone FS
    Front Pediatr; 2023; 11():1259384. PubMed ID: 37780052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoadsorption with CytoSorb in Septic Shock Reduces Catecholamine Requirements and In-Hospital Mortality: A Single-Center Retrospective 'Genetic' Matched Analysis.
    Rugg C; Klose R; Hornung R; Innerhofer N; Bachler M; Schmid S; Fries D; Ströhle M
    Biomedicines; 2020 Nov; 8(12):. PubMed ID: 33255912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with hemoadsorption (CytoSorb
    Mehta Y; Mehta C; Kumar A; George JV; Gupta A; Nanda S; Kochhar G; Raizada A
    World J Crit Care Med; 2020 Jan; 9(1):1-12. PubMed ID: 32104647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CytoSorb, a novel therapeutic approach for patients with septic shock: a case report.
    Hinz B; Jauch O; Noky T; Friesecke S; Abel P; Kaiser R
    Int J Artif Organs; 2015 Aug; 38(8):461-4. PubMed ID: 26349530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemoadsorption with CytoSorb
    Köhler T; Schwier E; Kirchner C; Winde G; Henzler D; Eickmeyer C
    J Artif Organs; 2022 Mar; 25(1):86-90. PubMed ID: 34047868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose CytoSorb hemoadsorption is associated with improved survival in patients with septic shock: A retrospective cohort study.
    Schultz P; Schwier E; Eickmeyer C; Henzler D; Köhler T
    J Crit Care; 2021 Aug; 64():184-192. PubMed ID: 33962219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the cytokine adsorber CytoSorb
    Scharf C; Weinelt F; Schroeder I; Paal M; Weigand M; Zoller M; Irlbeck M; Kloft C; Briegel J; Liebchen U
    Ann Intensive Care; 2022 May; 12(1):44. PubMed ID: 35599248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemoadsorption with CytoSorb shows a decreased observed versus expected 28-day all-cause mortality in ICU patients with septic shock: a propensity-score-weighted retrospective study.
    Brouwer WP; Duran S; Kuijper M; Ince C
    Crit Care; 2019 Sep; 23(1):317. PubMed ID: 31533846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine hemoadsorption with CytoSorb® in patients with sepsis: a systematic review and meta-analysis.
    Saldaña-Gastulo JJC; Llamas-Barbarán MDR; Coronel-Chucos LG; Hurtado-Roca Y
    Crit Care Sci; 2023; 35(2):217-225. PubMed ID: 37712812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemoadsorption in 'Liver Indication'-Analysis of 109 Patients' Data from the CytoSorb International Registry.
    Ocskay K; Tomescu D; Faltlhauser A; Jacob D; Friesecke S; Malbrain M; Kogelmann K; Bogdanski R; Bach F; Fritz H; Hartjes A; Kortgen A; Soukup J; Utzolino S; van Tellingen M; Träger K; Schumacher U; Brunkhorst FM; Molnar Z
    J Clin Med; 2021 Nov; 10(21):. PubMed ID: 34768702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit of Hemoadsorption Therapy in Patients Suffering Sepsis-Associated Acute Kidney Injury: A Case Series.
    Hakemi MS; Nassiri AA; Nobakht A; Mardani M; Darazam IA; Parsa M; Miri MM; Shahrami R; Koomleh AA; Entezarmahdi K; Karimi A
    Blood Purif; 2022; 51(10):823-830. PubMed ID: 35108714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb
    Berlot G; Samola V; Barbaresco I; Tomasini A; di Maso V; Bianco F; Gerini U
    Int J Artif Organs; 2022 Mar; 45(3):249-253. PubMed ID: 35075942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.